MACROGENICS, INC. Deferred Revenue
MACROGENICS, INC. (MGNX) had Deferred Revenue of $10.92 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-03-09
- 2025-12-31: Deferred Revenue, Current $10.92M.
- 2024-12-31: Deferred Revenue, Current $16.32M.
- 2023-12-31: Deferred Revenue, Current $21.65M.
- 2022-12-31: Deferred Revenue, Current $9.99M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2025-12-31 | $10.92M 10-K · filed 2026-03-09 | |
| 2024-12-31 | $16.32M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $21.65M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $9.99M 10-K · filed 2024-03-07 | |
| 2021-12-31 | $20.65M 10-K · filed 2023-03-15 | |
| 2020-12-31 | $4.46M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $10.70M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $21.72M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $7.38M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $8.00M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $8.12M 10-Q · filed 2018-05-07 | |
| 2018-01-01 | $7.74M 10-K · filed 2019-02-26 | |
| 2017-12-31 | $7.20M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $3.20M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $3.20M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $4.26M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $4.26M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $3.78M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $4.58M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $4.92M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $5.87M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $7.16M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $10.19M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $12.38M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $14.25M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $15.62M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $20.68M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $19.67M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $20.27M 10-K · filed 2015-03-03 | $20.27M 10-K · filed 2014-03-20 |
| 2013-09-30 | $21.30M 10-Q · filed 2013-11-12 | |
| 2012-12-31 | $24.12M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |